Small molecule drug companies develop low-molecular-weight medicines designed to interact with specific biological targets. These compounds can often enter cells and may be formulated as oral or other conventional dosage forms across a wide range of therapeutic areas.
This category includes companies working on:
Browse 202 UK small molecule drug companies below.
Integrated drug discovery services for biotech and pharma
BioAscent is a Scotland-based integrated drug discovery contract research organisation providing science-led services to biotech, pharmaceutical, and academic customers. Operating…
Computational chemistry and data informatics for drug discovery
NovaData Solutions is a contract research organisation providing computational chemistry, molecular modelling, and data informatics services to pharmaceutical and biotechnology…
Small molecule therapeutics targeting astrocytes in Parkinson's disease
Cellestial Health is a pre-clinical stage biotechnology company and University of Cambridge spinout developing small molecule therapeutics for Parkinson's disease and other…
Generic and branded prescription medicines development and supply
Northumbria Pharma is a pharmaceutical company specialising in the development, manufacture, licensing, and supply of generic and branded prescription medicines across primary and…
Phase 1 clinical research and bioanalytical services for drug development
Celerion is a contract research organisation specialising in early-stage clinical research for pharmaceutical and biotechnology clients. Operating from a dedicated Phase 1 clinic…
Cambridge R&D hub for GPCR-based drug discovery
Nxera Pharma UK is the Cambridge-based drug discovery arm of Tokyo-listed Nxera Pharma, formerly Sosei Heptares, operating from Granta Park with approximately 170 scientists. Its…
Not-for-profit research organisation targeting intrinsically disordered proteins
Bind Research is the UK's first Focused Research Organisation, established to make intrinsically disordered proteins druggable targets for new medicines. The organisation…
AI-powered molecular design software for medicinal chemists
deepmirror is a software company developing an AI-powered drug design application for medicinal chemists. Its no-code interface integrates generative molecular design with…
Fragment-based drug discovery platform for oncology and CNS disorders
Astex Pharmaceuticals is a drug discovery and development company pioneering fragment-based drug discovery through its proprietary Pyramid platform, applied to oncology and…
Small molecule CDMO delivering process chemistry and API manufacturing services
Onyx Scientific is a contract manufacturing organisation specialising in small molecule active pharmaceutical ingredients. The company supports pharma and biotech clients from…
CRISPR-engineered tumour-infiltrating lymphocyte therapy
Intima Bioscience is a clinical-stage biotechnology company developing CRISPR gene-edited tumour-infiltrating lymphocyte therapies for solid tumours. Its platform targets CISH, an…
AI-driven tRNA synthetase platform for novel small molecule therapeutics
Oxford Drug Design is an Oxford biotech developing small molecule therapeutics using an integrated platform combining aminoacyl-tRNA synthetase biology with proprietary generative…